United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - chlordiazepoxide hydrochloride (unii: mfm6k1xwdk) (chlordiazepoxide - unii:6rz6xez3cr) - chlordiazepoxide hydrochloride 25 mg - chlordiazepoxide hcl capsules are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the effectiveness of chlordiazepoxide hcl capsules in long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. chlordiazepoxide hcl capsules are contraindicated in patients with known hypersensitivity to the drug. chlordiazepoxide is a schedule iv controlled substance. chlordiazepoxide is a benzodiazepine and a cns depressant with a potential for abuse and addiction. abuse is the intentional, non-therapeutic use of a drug, even once, for its desirable psychological or physiological effects. misuse is the intentional use, for therapeutic pur

United States - English - NLM (National Library of Medicine)

vedco - propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - propylene glycol 3.45 kg in 3.45 kg - for use as an aid in prevention and treatment of ketosis (acetonemia) in dairy cattle. for animal use only keep out of reach of children livestock drug printed in u.s.a. take time observe label directions iss. 2-99 distributed by vedco, inc. st. joseph, mo 64504

United States - English - NLM (National Library of Medicine)

phoenix pharmaceutical inc./clipper distributing, inc. - propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - propylene glycol 3.45 kg in 3.45 kg - for use as an aid in prevention and treatment of ketosis (acetonemia) in dairy cattle. livestock drug take time observe label directions tradmarks are property of clipper distributing company, llc rev. 06-09

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets, usp (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14.1)]. bupropion hydrochloride extended-release tablets, usp (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets in the prevention of seasonal major depressive episodes was established in 3 placebo-controlled tri

United States - English - NLM (National Library of Medicine)

wockhardt limited - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14.1)] . bupropion hydrochloride extended-release tablets (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets in the prevention of seasonal major depressive episodes was established in 3 placebo-controlled trials in ad

United States - English - NLM (National Library of Medicine)

wockhardt usa llc. - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets, usp (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [ see clinical studies (14.1) ]. bupropion hydrochloride extended-release tablets, usp (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets in the prevention of seasonal major depressive episodes was estab

United States - English - NLM (National Library of Medicine)

durvet, inc. - propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - propylene glycol 3.785 l in 3.785 l - for use as an aid in prevention and treatment of ketosis livestock drug for animal use only keep out of reach of children indications for use as an aid in prevention and treatment of ketosis (acetonemia) in dairy cattle. consult veterinarian if condition does not respond.

United States - English - NLM (National Library of Medicine)

aspen veterinary resources, ltd - propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - propylene glycol 3.785 l in 3.785 l - for animal use only keep out of reach of children livestock drug indications for use as an aid in prevention and treatment for ketosis (acetonemia) in dairy cattle.

United States - English - NLM (National Library of Medicine)

vedco, inc. - propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - propylene glycol 1034.2 g in 1 l - for use as an aid in the prevention and treatment of ketosis (acetonemia) in dairy cattle.

United States - English - NLM (National Library of Medicine)

clipper distributing company, llc - propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3) - propylene glycol 3.785 g in 3.785 g